Antibodies against the activated coagulation Factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 8219-8225

  Yang, Yao Hsu ^a,b   Hwang, Kwan Ki ^a   FitzGerald, John ^a   Grossman, Jennifer M ^a   Taylor, Mihaela ^a   Hahn, Bevra H ^a   Chen, Pojen P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; THROMBIN ANTITHROMBIN COMPLEX;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; THROMBOSIS;

EID: 33751578678     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.8219     Document Type: Article

References (38)

1. Greaves, M. 1999. Antiphospholipid antibodies and thrombosis. Lancet 353: 1348-1353.
2. Wilson, W. A., A. E. Gharavi, T. Koike, M. D. Lockshin, D. W. Branch, J. C. Piette, R. Brey, R. Derksen, E. N. Harris, G. R. V. Hughes, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 42: 1309-1311.
3. Fleck, R. A., S. I. Rapaport, and L. V. Rao. 1988. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 72: 512-519.
4. McNeil, H. P., R. J. Simpson, C. N. Chesterman, and S. A. Krilis. 1990. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87: 4120-4124.
5. Matsuura, E., Y. Igarashi, M. Fujimoto, and K. Ichikawa. 1990. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336: 177-178.
6. Galli, M., P. Comfurius, C. Maassen, H. C. Hemker, M. H. de Baets, P. J. C. van Breda-Vriesman, T. Barbui, R. F. A. Zwaal, and E. M. Bevers. 1990. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335: 1544-1547.
7. Bevers, E. M., M. Galli, T. Barui, P. Comfurius, and R. F. A. Zwaal. 1991. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 66: 629-632.
8. Oosting, J. D., R. H. W. M. Derksen, I. W. G. Bobbink, T. M. Hackeng, B. N. Bouma, and P. G. de Groot. 1993. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 81: 2618-2625.
9. Rand, J. H., X. X. Wu, H. A. M. Andree, C. J. Lockwood, S. Guller, J. Scher, and P. C. Harpel. 1997. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N. Engl. J. Med. 337: 154-160.
10. Hwang, K. K., J. M. Grossman, S. Visvanathan, R. U. Chukwuocha, V. L. Woods, D. T. Le, B. H. Hahn, and P. P. Chen. 2001. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J. Immunol. 167: 7192-7198.
11. Hwang, K. K., C. D. Yang, W. Yan, J. M. Grossman, B. H. Hahn, and P. P. Chen. 2003. A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C. Arthritis Rheum. 48: 1622-1630.
12. Rand, J. H., X. X. Wu, A. S. Quinn, P. P. Chen, K. R. McCrae, E. G. Bovill, and D. J. Taatjes. 2003. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am. J. Pathol. 163: 1193-1200.
13. Yang, C. D., K. K. Hwang, W. Yan, K. Gallagher, J. FitzGerald, J. M. Grossman, B. H. Hahn, and P. P. Chen. 2004. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J. Immunol. 172: 5765-5773.
14. Lu, C. S., A. A. Horizon, K. K. Hwang, J. Fitzgerald, W. S. Lin, B. H. Hahn, D. J. Wallace, A. L. Metzger, M. H. Weisman, and P. P. Chen. 2005. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum. 52: 4018-4027.
15. Mather, T., V. Oganessyan, P. Hof, R. Huber, S. Foundling, C. Esmon, and W. Bode. 1996. The 2.8 angstrom crystal structure of gla-domainless activated protein C. EMBO J. 15: 6822-6831.
16. St Charles, R., J. Matthews, E. Zhang, and A. Tulinsky. 1999. Bound structures of novel p3-p1′ β-strand mimetic inhibitors of thrombin. J. Med. Chem. 42: 1376-1383.
17. Wang, X., X. Lin, J. A. Loy, J. Tang, and X. C. Zhang. 1998. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science 281: 1662-1665.
18. Branch, D. W., D. J. Dudley, M. D. Mitchell, K. A. Creightari, J. M. Abott, E. H. Hammond, and R. A. Daynes. 1990. Immunoglobulin G fractions from patients with antiphospholipid antibodies caused fetal death in BALB/c mice: a model for autoimmune fetal loss. Am. J. Obstet. Gynecol. 163: 210-216.
19. Pierangeli, S. S., X. Liu, J. H. Barker, G. Anderson, and E. N. Harris. 1995. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb. Haemost. 74: 1361-1367.
20. Dahlback, B. 2000. Blood coagulation. Lancet 355: 1627-1632.
21. Esmon, C. T. 2000. Regulation of blood coagulation. Biochim. Biophys. Acta 1477: 349-360.
22. Olson, S. T., I. Bjork, and J. D. Shore. 1993. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol. 222: 525-559.
23. Pearson, J. D. 1999. Endothelial cell function and thrombosis. Bailliere's Clin. Haematol. 12: 329-341.
24. Kottke-Marchant, K., and A. Duncan. 2002. Antithrombin deficiency: issues in laboratory diagnosis. Arch. Pathol. Lab. Med. 126: 1326-1336.
25. Pierangeli, S. S., X. W. Liu, R. Espinola, T. Olee, M. Zhu, N. E. Harris, and P. P. Chen. 2000. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb. Haemost. 84: 388-395.
26. Furie, B., D. H. Bing, R. J. Feldmann, D. J. Robison, J. P. Burnier, and B. C. Furie. 1982. Computer-generated models of blood coagulation factor Xa, factor IXa, and thrombin based upon structural homology with other serine proteases. J. Biol. Chem. 257: 3875-3882.
27. Rose, T., and E. Di Cera. 2002. Substrate recognition drives the evolution of serine proteases. J. Biol. Chem. 277: 19243-19246.
28. Zhu, M., T. Olee, D. T. Le, R. A. S. Roubey, B. H. Hahn, V. L. Jr. Woods, and P. P. Chen. 1999. Characterization of IgG monoclonal anti-cardiolipin/ antib2GP1 antibodies from two patients with the anti-phospholipid syndrome reveals three species of antibodies. Br. J. Haematol. 105: 102-109.
29. Zhao, Y., R. Rumold, A. E. Ahmed, D. T. Le, B. H. Hahn, V. L. Woods, Jr., and P. P. Chen. 1999. An IgG anti-prothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times. Arthritis Rheum. 42: 2132-2138.
30. Wiebe, E. M., A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz. 2003. Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide. J. Biol. Chem. 278: 35767-35774.
31. Stenflo, J. 1991. Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. Blood 78: 1637-1651.
32. Greenber, C. S., and C. L. Orthner. 1999. Blood coagulation and fibrinolysis. In Wintrobe's Clinical Hematology, G. R. Lee, J. Foerster, J. Lukens, F. Paraskevas, J. P. Greer, and G. M. Rogers, eds. Williams & Wilkins, Baltimore, p. 684-764.
33. Roubey, R. A. S. 1994. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other " antiphospholipid" autoantibodies. Blood 84: 2854-2867.
34. Quinsey, N. S., A. L. Greedy, S. P. Bottomley, J. C. Whisstock, and R. N. Pike. 2004. Antithrombin: in control of coagulation. Int. J. Biochem. Cell Biol. 36: 386-389.
35. Jin, L., J. Abrahams, R. Skinner, M. Petitou, R. Pike, and R. Carrell. 1997. The anticoagulant activation of antithrombin by heparin. Proc. Natl. Acad. Sci. USA 94: 14683-14688.
36. Huntington, J. A., A. McCoy, K. J. Belzar, X. Y. Pei, P. G. Gettins, and R. W. Carrell. 2000. The conformational activation of antithrombin: a 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions. J. Biol. Chem. 275: 15377-15383.
37. Gettins, P. G. 2002. Serpin structure, mechanism, and function. Chem. Rev. 102: 4751-4804.
38. 2+-dependent fashion and modulate its catalytic activity. Biochemistry 42: 13091-13098.